Mkts

Caribou Biosciences, Inc.

NASDAQ: CRBU
$0.31-0.02 (-4.75%)
As of Nov 19, 9:30 AM ET

Key statistics

Day range
0.300.34
52-week range
0.302.49
Today
Open0.33
Previous close0.31
Volume1.81M
Valuation
Market cap33.55M
P/E ratio—
EPS (TTM)-1.03
Income & risk
Dividend / yield—
Beta2.65
Avg volume2.27M
Discussion

CRBU News

Stories mentioning CRBU from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue2,3973,9412,1982,6672,3532,0772,0243,464
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development20,61123,81522,40127,69235,53130,46430,42135,480
Sales General & Admin
Total Operating Expenses28,67732,39431,59850,24545,26640,95240,26246,965
Operating Income (Loss)(26,280)(28,453)(29,400)(47,578)(42,913)(38,875)(38,238)(43,501)
Interest Income
Interest Expense
Other Expense
Pretax Income
Tax Provision0.000.000.00(9.00)0.000.00
Net Income (Loss)(25,085)(26,488)(27,548)(54,098)(39,991)(35,490)(34,684)(37,697)
Earnings Per Share (Basic)(0.26)(0.28)(0.30)(0.58)(0.43)(0.39)(0.38)(0.42)
Earnings Per Share (Diluted)(0.26)(0.28)(0.30)(0.58)(0.43)(0.39)(0.38)(0.42)
Weighted Average Shares Outstanding (Basic)95,86293,38993,29393,02992,67990,31890,45690,341
Weighted Average Shares Outstanding (Diluted)95,86293,38993,29393,02992,67990,31890,45690,341

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About CRBU

Caribou Biosciences, Inc. (NASDAQ: CRBU) is a stock listed on the Nasdaq Stock Market under the ticker symbol CRBU. It last traded at $0.3100 (Nov 19, 2026, 9:30 AM ET), down 4.8% on the day. That gives Caribou Biosciences a market capitalisation of $33.5M.

Over the past 52 weeks CRBU has traded between $0.3000 and $2.49.

Revenue for the quarter ended Mar 31, 2026 was $2.4M; a net loss of $25.1M. Revenue was up 1.9% from $2.4M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$2.4M-$25.1M-1046.5%
Dec 31, 2025$3.9M-$26.5M-672.1%
Sep 30, 2025$2.2M-$27.5M-1253.3%
Jun 30, 2025$2.7M-$54.1M-2028.4%

From Caribou Biosciences’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…